References
- Tu TM, Goh C, Tan YK, et al. Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis. 2020;29(12):105379. doi:10.1016/j.jstrokecerebrovasdis.2020.105379.
- Frank G, Smith J, Davies B, Mirsky D, Hink E, Durairaj V. Ophthalmic manifestations and outcomes after cavernous sinus thrombosis in children. J Am Assoc Pediatr Ophthalmol Strabismus. 2015;19(4):358–362. doi:10.1016/j.jaapos.2015.06.001.
- Ebright JR, Pace MT, Niazi AF. Septic thrombosis of the cavernous sinuses. Arch Intern Med. 2001;161(22):2671–2676. doi:10.1001/archinte.161.22.2671.
- Khacha A, Bouchal S, Ettabyaoui A, et al. Cavernous sinus thrombosis in a COVID-19 patient: a case report. Radiol Case Rep. 2021;16(3):480–482. doi:10.1016/j.radcr.2020.12.013.
- Branson SV, McClintic E, Yeatts RP. Septic cavernous sinus thrombosis associated with orbital cellulitis: a report of 6 cases and review of literature. Ophthalmic Plast Reconstr Surg. 2019;35(3):272–280. doi:10.1097/IOP.00000000000012317.
- Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: a typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29(8):104989. doi:10.1016/j.jstrokecerebrovasdis.2020.104989.
- Komatsu H, Matsumoto F, Kasai M, Kurano K, Sasaki D, Ikeda K. Cavernous sinus thrombosis caused by contralateral sphenoid sinusitis: a case report. Head Face Med. 2013;9:9. doi:10.1186/1746-160X-9-9.
- Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020;21(3):315–319. doi:10.31083/j.rcm.2020.03.126.
- Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988;38(4):517–522. doi:10.1212/wnl.38.4.517.